Enhanced Genomics

Cambridge, United Kingdom · Founded 2020 · Privately Held (backing)

Developer of a biotechnology platform designed to develop tools for large-scale analysis of genetic variations and gene function. Enhanced Genomics is based in Cambridge, United Kingdom and was founded in 2020. Its last reported valuation was $28.1 million in Sep 2025. It has raised $21.8 million.

Last reported valuation

$28.1M

Oct 2026

Priced at

—

Total raised

$21.8M

Last round

—

How much has Enhanced Genomics raised?

$21.8Macross 0 recorded rounds

Free account

More of Enhanced Genomics with a free account

·Watch Enhanced Genomics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Enhanced Genomics investors

9 investors are on record for Enhanced Genomics, including BGF (Financial Services), Parkwalk Advisors, Meltwind Advisory and Jonathan Milner.

For fundraisers

Raising for a company like Enhanced Genomics?

9 investors have backed Enhanced Genomics.

See all 9 investors →

Frequently asked about Enhanced Genomics

How much has Enhanced Genomics raised?: Enhanced Genomics has raised $21.8M in total across 0 recorded funding rounds.